Drugs / Alutard Phleum pratense
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05191186 Comparator | Feb 2020 → Aug 2023 | allergic asthma, conjunctivitis, seasonal allergic rhinitis | Aarhus University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alutard Phleum pratense | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05191186 ↗ |
| Route | Other | “3 intralymphatic injections with a low dose of grass pollen extract into inguinal lymph nodes” NCT05191186 ↗ |